16-hydroxyestrone has been researched along with 3,3'-diindolylmethane in 2 studies
| Studies (16-hydroxyestrone) | Trials (16-hydroxyestrone) | Recent Studies (post-2010) (16-hydroxyestrone) | Studies (3,3'-diindolylmethane) | Trials (3,3'-diindolylmethane) | Recent Studies (post-2010) (3,3'-diindolylmethane) |
|---|---|---|---|---|---|
| 149 | 17 | 25 | 409 | 16 | 252 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradlow, HL; Kotsopoulos, J; Llacuachaqui, M; Narod, SA; Nikitina, D; Sepkovic, D | 1 |
| Altbach, M; Chalasani, P; Chow, HHS; Galons, JP; Huang, C; Maskarinec, G; Roe, DJ; Stopeck, A; Strom, MB; Thompson, PA; Thomson, CA; Wertheim, BC | 1 |
1 trial(s) available for 16-hydroxyestrone and 3,3'-diindolylmethane
| Article | Year |
|---|---|
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Double-Blind Method; Female; Humans; Hydroxyestrones; Indoles; Mammography; Middle Aged; Sex Hormone-Binding Globulin; Tamoxifen; Time Factors; Treatment Outcome | 2017 |
1 other study(ies) available for 16-hydroxyestrone and 3,3'-diindolylmethane
| Article | Year |
|---|---|
The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers.
Topics: Administration, Oral; Adult; Female; Genes, BRCA1; Heterozygote; Humans; Hydroxyestrones; Indoles; Middle Aged; Mutation | 2015 |